{"query":"DermTech Bret Christensen melanoma detection commercialization","follow_up_questions":null,"answer":null,"images":[],"results":[{"url":"https://seekingalpha.com/article/4612423-dermtech-inc-new-ceo-same-challenges","title":"DermTech, Inc.: New CEO, Same Challenges - Seeking Alpha","content":"DermTech's new CEO, Bret Christensen, faces the challenge of commercializing SmartSticker solution and increasing sales momentum.","score":0.69274646,"raw_content":null},{"url":"https://www.sandiegouniontribune.com/business/story/2024-02-06/dermtech-the-san-diego-biotech-making-a-skin-cancer-detecting-patch-cuts-15-of-workforce/","title":"DermTech, the San Diego biotech making a skin-cancer detecting ...","content":"The commercial test has not been reviewed or approved by the U.S. Food and Drug Administration. However, DermTech's melanoma test has gained","score":0.57666177,"raw_content":null},{"url":"https://www.massdevice.com/former-insulet-exec-dermtech-president-ceo/","title":"Former Insulet exec named DermTech president and CEO","content":"DermTech (Nasdaq:DMTK) announced today that it appointed Bret Christensen as president, CEO and a member of the board.","score":0.5402697,"raw_content":null},{"url":"https://www.sec.gov/Archives/edgar/data/1651944/000165194423000077/dmtk-20230630.htm","title":"dmtk-20230630 - SEC.gov","content":"The DermTech Melanoma Test (“DMT”) facilitates the clinical assessment of pigmented skin lesions for melanoma. We initially marketed this test directly to a","score":0.528169,"raw_content":null},{"url":"https://practicaldermatology.com/news/dermtech-appoints-bret-christensen-as-new-president-and-ceo/2461707/","title":"DermTech Appoints Bret Christensen as New President and CEO","content":"Christensen served as chief commercial officer of Insulet from May 2017 to May 2023 where he oversaw sales growth from approximately $367","score":0.51866865,"raw_content":null}],"response_time":0.83,"request_id":"424e7460-5737-42c7-9d78-e3592eecafb0"}